Related Experiment Video

Updated: Jun 27, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

PTEN regulation by Akt-EGR1-ARF-PTEN axis

Jianxiu Yu1, Sharon S Zhang, Kan Saito

  • 1The Burnham Institute for Medical Research, La Jolla, CA 92037, USA. jianxiu.Yu@gmail.com

The EMBO Journal
|December 6, 2008
PubMed

Insights

The Akt-EGR1-alternate reading frame (ARF)-PTEN axis reveals that p14ARF-mediated sumoylation of EGR1 is crucial for PTEN activation. This pathway highlights the interconnectedness of key tumor suppressors PTEN, EGR1, and ARF.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • The PTEN tumor suppressor gene's induction is linked to the EGR1 transcription factor.
  • EGR1 also activates other pro-apoptotic and anti-cancer genes like p53, p73, and p300/CBP.

Purpose of the Study:

  • To elucidate a novel signaling axis involving Akt, EGR1, ARF, and PTEN.
  • To investigate the mechanism of PTEN activation in vivo and its regulation by EGR1 and ARF.

Main Methods:

  • Investigated the Akt-EGR1-ARF-PTEN pathway using in vivo models.
  • Examined the role of p14ARF-mediated sumoylation of EGR1 in PTEN activation.
  • Analyzed the dependency of EGR1 sumoylation on Akt phosphorylation and ARF interaction.

Main Results:

  • Identified a novel Akt-EGR1-ARF-PTEN axis where PTEN activation requires p14ARF-mediated sumoylation of EGR1.
  • Demonstrated that Akt phosphorylates EGR1, promoting its interaction with ARF for sumoylation via the ARF/Ubc9/SUMO system.
  • Observed reduced EGR1 sumoylation and PTEN levels in ARF-deficient conditions and mice.

Conclusions:

  • Perturbation of PTEN, EGR1, or ARF leads to dysfunction in the others, underscoring their interconnected roles in cancer suppression.
  • The findings explain the negative feedback regulation of PTEN synthesis via PI3K inhibition.
  • This axis provides new insights into tumor suppressor gene regulation and potential therapeutic targets.

More Related Videos

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications10:12

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

Published on: April 21, 2023

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...